We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Bladder Cancer

Journal Scan / Research · November 23, 2021

Synergistic Antitumor Activity of Pan-PI3K Inhibition and Immune Checkpoint Blockade in Bladder Cancer

Journal for immunotherapy of cancer

 

Additional Info

Journal for immunotherapy of cancer
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
J Immunother Cancer 2021 Nov 01;9(11)e002917, S Zhu, AH Ma, Z Zhu, E Adib, T Rao, N Li, K Ni, VCSR Chittepu, R Prabhala, J Garisto Risco, D Kwiatkowski, K Mouw, G Sonpavde, F Cheng, CX Pan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading